Genomma Enjoys Strong Q2 Thanks To Big Gains in US

Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation. 

Concept The border between Mexico and America, a magnifying glass over the world map of Mexico
• Source: Shutterstock

Mexico’s Genomma Lab Internacional SAB de CV reported OTC sales up by 32.2% to MXN1.96bn ($86.9m) in the second quarter of 2020 as turnover advanced significantly two of its three reporting regions.

New product launches and increasing numbers of points of sale for its OTC products had been behind the strong double-digit...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business